KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Operating Expenses: 2015-2025

Historic Operating Expenses for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $518.1 million.

  • Medpace Holdings' Operating Expenses rose 23.05% to $518.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 11.39%. This contributed to the annual value of $1.7 billion for FY2024, which is 7.31% up from last year.
  • Latest data reveals that Medpace Holdings reported Operating Expenses of $518.1 million as of Q3 2025, which was up 8.62% from $477.0 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Operating Expenses registered a high of $518.1 million during Q3 2025, and its lowest value of $212.4 million during Q1 2021.
  • Moreover, its 3-year median value for Operating Expenses was $411.2 million (2024), whereas its average is $422.8 million.
  • Data for Medpace Holdings' Operating Expenses shows a peak YoY skyrocketed of 34.87% (in 2021) over the last 5 years.
  • Medpace Holdings' Operating Expenses (Quarterly) stood at $253.7 million in 2021, then increased by 25.22% to $317.7 million in 2022, then increased by 29.41% to $411.1 million in 2023, then increased by 0.03% to $411.2 million in 2024, then grew by 23.05% to $518.1 million in 2025.
  • Its last three reported values are $518.1 million in Q3 2025, $477.0 million for Q2 2025, and $445.0 million during Q1 2025.